Codes / ICD10CM / M1A.2310

M1A.2310 Drug-induced chronic gout, right wrist, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Right Wrist, Without Tophus (tophi)

Summary

Drug-induced chronic gout, right wrist, without tophus is a form of arthritis affecting the right wrist joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the presence of tophi (urate crystal deposits) in this stage.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the right wrist joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense right wrist pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected wrist
  • Stiffness and limited range of motion in the wrist
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis may identify urate crystals. Imaging such as X-rays or ultrasound can assess joint damage and rule out other conditions. The absence of tophi is confirmed through physical examination and imaging.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs (e.g., NSAIDs or colchicine). Lifestyle modifications, such as dietary changes and hydration, may also be recommended. In some cases, discontinuing the causative drug may be necessary.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is important to monitor uric acid levels and adjust treatment as needed. Long-term adherence to therapy is often required to prevent recurrence and progression.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, reduced mobility, and potential deformity. Recurrent flare-ups can impact quality of life, and in rare cases, severe inflammation may cause nerve compression or infection.

Lifestyle & Prevention

  • Avoid medications known to raise uric acid levels when possible.
  • Maintain a balanced diet low in purines (e.g., limit red meat, seafood).
  • Stay hydrated to support kidney function.
  • Limit alcohol consumption, particularly beer and spirits.
  • Engage in regular, low-impact exercise to support joint health.

When to Seek Professional Help

Seek medical attention if you experience sudden, severe right wrist pain, swelling, or redness, or if symptoms persist despite home care. Prompt evaluation is important to prevent complications and adjust treatment.

Tips for Medical Coders

Document the specific site (right wrist) and absence of tophi clearly in the medical record. Ensure the causative drug is identified and linked to the condition. Follow ICD-10-CM guidelines for coding drug-induced conditions, specifying the affected joint and absence of tophi as required.

Book a walkthrough

M1A.2310 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.